Pfizer Inc.

Stocks

Market Closed - NYSE Other stock markets 04:01:48 2026-07-10 pm EDT			5-day change	1st Jan Change
24.17 ^USD	-0.33%		-0.62%	-2.93%

Jul. 10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ
Jul. 10	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ

Published on 06/17/2026 at 03:37 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day everyone and welcome to Pfizer Flash Live from ADA, spotlighting berobenatide, an investigational potential first-in-class monthly GLP-1

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Jul. 10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ
Jul. 10	Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA	DJ
Jul. 10	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says	MT
Jul. 10	Pfizer Poised for Mixed Second Quarter, RBC Says	MT
Jul. 10	Pfizer Inc. and Astellas Pharma Inc. Receive U.S. FDA Approval for PADCEV Plus Keytruda as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer	CI
Jul. 10	BofA Securities Adjusts Pfizer Price Target to $26 From $27	MT
Jul. 10	PFIZER INC : RBC reiterates its Neutral rating	ZD
Jul. 10	Pfizer Seen Reporting Q2 Revenue In Line With Consensus, EPS Below Estimates, RBC Says	MT
Jul. 10	Polish air traffic control faces funding freeze over COVID vaccine ruling	RE
Jul. 10	Pfizer's Vaccine Disputes With Poland, Romania Continue	MT
Jul. 10	UK Stocks-Factors to watch on July 10	RE
Jul. 09	US Appeals Court Upholds Ruling in Favor of AstraZeneca in Patent Case Against Pfizer Unit	MT
Jul. 09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
Jul. 09	AstraZeneca Wins Pfizer Patent Battle Over Cancer Drug	MT
Jul. 09	AstraZeneca's Wainua fails key heart disease trial, shares tumble	RE